Breaking News

U.S. Says 72-Hour Cease-Fire Agreed in Gaza, to Start Tomorrow
Tweet TWEET

Sarepta Therapeutics to Announce Second Quarter 2013 Financial Results and Corporate Update on August 8, 2013

Sarepta Therapeutics to Announce Second Quarter 2013 Financial Results and 
Corporate Update on August 8, 2013 
CAMBRIDGE, MA -- (Marketwired) -- 07/25/13 --   Sarepta Therapeutics,
Inc. (NASDAQ: SRPT), a developer of innovative RNA-based
therapeutics, will report second quarter financial results before the
NASDAQ Global Market opens on Thursday, August 8, 2013. Subsequently,
at 8:00 a.m., Eastern Time (5:00 a.m., Pacific Time), Chris
Garabedian, Sarepta's president and chief executive officer, and
Sandy Mahatme, Sarepta's chief financial officer, will host a
conference call to discuss second quarter financial results and to
provide a corporate update.  
The conference call may be accessed by dialing 888.895.5271 for
domestic callers and 847.619.6547 for international callers. The
passcode for the call is 35366636. Please specify to the operator
that you would like to join the "Sarepta Second Quarter Earnings
Call." The conference call will be webcast live under the investor
relations section of Sarepta's website at www.sarepta.com and will be
archived there following the call for 90 days. Please connect to
Sarepta's website several minutes prior to the start of the broadcast
to ensure adequate time for any software download that may be
necessary.  
About Sarepta Therapeutics 
Sarepta Therapeutics is focused on developing first-in-class
RNA-based therapeutics to improve and save the lives of people
affected by serious and life-threatening rare and infectious
diseases. The Company's diverse pipeline includes its lead program
eteplirsen, for Duchenne muscular dystrophy, as well as potential
treatments for some of the world's most lethal infectious diseases.
Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs.
For more information, please visit us at www.sarepta.com. 
Sarepta Investor Contact:
Erin Cox
857.242.3714
ecox@sarepta.com 
Sarepta Media Contact:
Jim Baker
857.242.3710
jbaker@sarepta.com